Clinical Trial Update: Reduced Dose Radiotherapy Following High Dose Chemotherapy in Intracranial Non-germinomatous Germ Cell Tumor [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating reduced-dose radiotherapy after high-dose chemotherapy in intracranial non-germinomatous germ cell tumor.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intracranial Non-germinomatous Germ Cell Tumor

Snippet

Sponsor: Samsung Medical Center | Conditions: Intracranial Non-germinomatous Germ Cell Tumor | Phase 2 | Status: UNKNOWN